Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
Zecca C, Heldner MR, Kamm CP, Riccitelli GC, Disanto G, Caporro M, Cianfoni A, Pravatà E, Gobbi C. Zecca C, et al. Expert Opin Biol Ther. 2015 May;15(5):633-40. doi: 10.1517/14712598.2015.1025046. Epub 2015 Apr 3. Expert Opin Biol Ther. 2015. PMID: 25840751
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Disanto G, Benkert P, Lorscheider J, Mueller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue EW, Sprenger T, Stippich C, Derfuss T, Louvion JF, Kamm CP, Mattle HP, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive PH, Yaldizli Ö, Gobbi C, Kappos L, Kuhle J; SMSC Scientific Board. Disanto G, et al. Among authors: zecca c. PLoS One. 2016 Mar 31;11(3):e0152347. doi: 10.1371/journal.pone.0152347. eCollection 2016. PLoS One. 2016. PMID: 27032105 Free PMC article.
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss Multiple Sclerosis Cohort Study Group. Disanto G, et al. Among authors: zecca c. Ann Neurol. 2017 Jun;81(6):857-870. doi: 10.1002/ana.24954. Ann Neurol. 2017. PMID: 28512753 Free PMC article.
Prodromal symptoms of multiple sclerosis in primary care.
Disanto G, Zecca C, MacLachlan S, Sacco R, Handunnetthi L, Meier UC, Simpson A, McDonald L, Rossi A, Benkert P, Kuhle J, Ramagopalan SV, Gobbi C. Disanto G, et al. Among authors: zecca c. Ann Neurol. 2018 Jun;83(6):1162-1173. doi: 10.1002/ana.25247. Epub 2018 May 30. Ann Neurol. 2018. PMID: 29740872
Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categories.
Kaufmann M, Salmen A, Barin L, Puhan MA, Calabrese P, Kamm CP, Gobbi C, Kuhle J, Manjaly ZM, Ajdacic-Gross V, Schafroth S, Bottignole B, Ammann S, Zecca C, D'Souza M, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR). Kaufmann M, et al. Among authors: zecca c. Mult Scler Relat Disord. 2020 Jul;42:102148. doi: 10.1016/j.msard.2020.102148. Epub 2020 Apr 28. Mult Scler Relat Disord. 2020. PMID: 32371376 Free article.
Factors associated with employment and expected work retention among persons with multiple sclerosis: findings of a cross-sectional citizen science study.
Lehmann AI, Rodgers S, Kamm CP, Mettler M, Steinemann N, Ajdacic-Gross V, Kaufmann M, Kesselring J, Calabrese P, Salmen A, Gobbi C, Zecca C, Bauer GF, von Wyl V. Lehmann AI, et al. Among authors: zecca c. J Neurol. 2020 Oct;267(10):3069-3082. doi: 10.1007/s00415-020-09973-3. Epub 2020 Jun 11. J Neurol. 2020. PMID: 32529580 Free PMC article.
Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis.
Fortunato R, van der Maas NA, Biland-Thommen U, Kaufmann M, Sieber C, Kamm CP, Zecca C, Gobbi C, Chan A, Calabrese P, Kesselring J, von Wyl V; Swiss Multiple Sclerosis Registry. Fortunato R, et al. Among authors: zecca c. Mult Scler Relat Disord. 2021 Feb;48:102710. doi: 10.1016/j.msard.2020.102710. Epub 2020 Dec 23. Mult Scler Relat Disord. 2021. PMID: 33370648 Free article.
Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Rodgers S, Calabrese P, Ajdacic-Gross V, Steinemann N, Kaufmann M, Salmen A, Manjaly ZM, Kesselring J, Kamm CP, Kuhle J, Chan A, Gobbi C, Zecca C, Müller S, von Wyl V. Rodgers S, et al. Among authors: zecca c. J Psychosom Res. 2021 May;144:110402. doi: 10.1016/j.jpsychores.2021.110402. Epub 2021 Feb 16. J Psychosom Res. 2021. PMID: 33631437 Free article.
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
Oechtering J, Schaedelin S, Benkert P, Müller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Fischer-Barnicol B, Orleth A, Chan A, Pot C, Barakovic M, Rahmanzadeh R, Galbusera R, Heijnen I, Lalive PH, Wuerfel J, Subramaniam S, Aeschbacher S, Conen D, Naegelin Y, Maceski A, Meier S, Berger K, Wiendl H, Lincke T, Lieb J, Yaldizli Ö, Sinnecker T, Derfuss T, Regeniter A, Zecca C, Gobbi C, Kappos L, Granziera C, Leppert D, Kuhle J; Swiss Multiple Sclerosis Cohort Study. Oechtering J, et al. Among authors: zecca c. Ann Neurol. 2021 Sep;90(3):477-489. doi: 10.1002/ana.26137. Epub 2021 Jun 22. Ann Neurol. 2021. PMID: 34057235 Free PMC article.
201 results